Home Calista Therapeutics

Calista Therapeutics

In operation
-
Specialized Peptide Drug Developer
Basic
Enterprise Profile

Basic Information

Calista Therapeutics is dedicated to developing specialized peptide drugs for cystic fibrosis, which will take 12 months from IND enabling to clinical trials.
Calista Therapeutics
RhodeIsland,United States of America
less than 15 people
January 01, 2012
info@calistatherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Protein Technology
Concept
Disease Treatment Respiratory Diseases Digestive System Diseases Rare Diseases
Application Scenarios
Biologics Innovative Drugs